Recombinant tandem protein and fusion protein for improving learning and memory ability, and coding gene and application of recombinant tandem protein and fusion protein

By designing and preparing a recombinant tandem protein, DNA recombination technology is used to solve the problem of time-consuming and low yield of walnut peptide preparation in the existing technology, and the protein with improved learning and memory ability is prepared through DNA recombination technology, which significantly improves the Mice learn and memory ability, providing potential for food and drug development.

CN118930657APending Publication Date: 2024-11-12ZHEJIANG FORESTRY UNIVERSITY
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202410976283.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-20
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

There is a lack of a protein that can be prepared by DNA recombination technology and has improved learning and memory ability, and the preparation method of walnut peptide is time-consuming, costly and low yield.

Method used

A recombinant tandem protein is designed with the general formula (YZY)n or GS-(YZY)n-SG, and is prepared by DNA recombination technology. By inducing expression and purification, a recombinant tandem protein with improved learning and memory ability was obtained, and the Applied in food and health products.

Benefits of technology

Through the D-galactose-induced memory injury model mouse water maze test, it was proved that recombinant tandem protein can significantly improve the learning and memory ability of mice, providing an efficient and economical potential to improve memory food and drug development.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118930657A_ABST
    Figure CN118930657A_ABST
Patent Text Reader

Abstract

The invention provides a recombinant tandem protein for improving learning and memory ability, a fusion protein and a coding gene and application thereof, and belongs to the technical field of bioengineering. The general formula of the recombinant tandem protein is (YZY) n, GS-(YZY) n or GS-(YZY) n-SG, Y is a trypsin cutting site, Z is an active peptide, and n is a tandem repeat number; n is greater than or equal to 2; the amino acid sequence of the active peptide is as shown in SEQ ID NO. 1. According to the invention, the walnut derived peptide EVSGPGYSPN is used as a template, and the recombinant tandem protein is designed and obtained; the recombinant tandem protein can be used as a target protein and is prepared by adopting a DNA (Deoxyribose Nucleic Acid) recombination technology. A D-galactose induced memory impairment model mouse water maze test proves that the recombinant tandem protein has the effect of improving the learning and memory ability of a mouse.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of bioengineering, and in particular relates to a recombinant tandem protein and fusion protein for improving learning and memory ability, and a coding gene and application thereof. Background Art

[0002] Walnuts are often called "brain-boosting foods". Walnut meal contains about 40% to 45% protein, including 8 essential amino acids for the human body. Walnut peptides extracted from walnut meal hydrolysate play an important role in improving memory and relieving neuroinflammation. For example, patent CN 114751957A discloses that the derivative peptide EVSGPGYSPN of the walnut antioxidant active peptide EVSGPGLSPN can penetrate the blood-brain barrier and improve the learning and memory ability of mice.

[0003] At present, the main preparation method of walnut peptide is to use walnut protein as raw material and prepare it by enzymatic hydrolysis, but this process is time-consuming and labor-intensive, and has high cost and low yield. In addition, the preparation method of walnut peptide also includes chemical synthesis and DNA recombination technology. Among them, the sequence directly synthesized by chemical synthesis is short and the synthesis efficiency is low. Although DNA recombination technology has the advantage of high synthesis efficiency, it is limited to the production of large peptides. At present, there is a lack of a protein that can be prepared by DNA recombination technology and has the effect of improving learning and memory ability. Summary of the invention

[0004] The purpose of the present invention is to provide a recombinant tandem protein, fusion protein and its encoding gene and application for improving learning and memory ability. The recombinant tandem protein of the present invention has the function of improving learning and memory ability and can be prepared by DNA recombination technology.

[0005] The present invention provides a recombinant tandem protein for improving learning and memory ability, the general formula of which is shown in Formula 1, Formula 2 or Formula 3; in Formula 1, Formula 2 or Formula 3, Y is a trypsin cleavage site, Z is an active peptide, and n is a tandem repeat number; n≥2; the amino acid sequence of the active peptide is shown in SEQ ID NO.1; (YZY)n Formula 1; GS-(YZY)n Formula 2; GS-(YZY)n-SG Formula 3.

[0006] Preferably, the molecular weight of the recombinant tandem protein is 15 to 35 kDa; n is 18 or 12; when n is 18, the amino acid sequence of the recombinant tandem protein is as shown in SEQ ID NO.2 or SEQ ID NO.3; when n is 12, the amino acid sequence of the recombinant tandem protein is as shown in SEQ ID NO.4.

[0007] The present invention also provides a gene encoding the recombinant tandem protein described in the above scheme.

[0008] The present invention also provides a fusion protein, the general formula of which is shown in Formula 4, Formula 5 or Formula 6; in Formula 4, Formula 5 or Formula 6, each protein group is connected in series in sequence; in Formula 4 and Formula 5, L1 is a first protein purification tag, X is a TEV cleavage site, Y is a trypsin cleavage site, Z is an active peptide, and n is a tandem repeat number; n≥2; in Formula 6, L2 is a second protein purification tag, X is a TEV cleavage site, Y is a trypsin cleavage site, Z is an active peptide, and n is a tandem repeat number; n≥2; L1-X-(YZY)nX-L1 is Formula 4; L1-X-(YZY)n is Formula 5; L2-X-(YZY)n is Formula 6; L1 is preferably a GST tag and a His tag connected in series in sequence; L2 is preferably a His tag.

[0009] The present invention also provides a gene encoding the fusion protein described in the above scheme.

[0010] The present invention also provides a recombinant plasmid into which the coding gene of the fusion protein described in the above scheme is inserted.

[0011] The present invention also provides a recombinant bacterium comprising the recombinant plasmid described in the above scheme.

[0012] The present invention also provides the use of the recombinant tandem protein, the encoding gene of the recombinant tandem protein, the fusion protein, the encoding gene of the fusion protein, the recombinant plasmid or the recombinant bacteria described in the above scheme in the preparation of a product for improving learning and memory ability.

[0013] The present invention also provides a method for preparing the recombinant tandem protein described in the above scheme, comprising the following steps:

[0014] The recombinant bacteria described in the above scheme are mixed with an inducer, and induced culture is performed to obtain an induced expression product; the bacterial precipitate in the induced expression product is first purified to obtain a first purified product; the first purified product is enzymatically digested with TEV enzyme to obtain an enzymatic digestion product; the enzymatic digestion product is second purified to obtain a recombinant tandem protein.

[0015] The present invention also provides a product for improving learning and memory ability, wherein the active ingredient comprises the recombinant tandem protein described in the above scheme or the recombinant tandem protein prepared by the preparation method.

[0016] The present invention provides a recombinant tandem protein for improving learning and memory ability, the general formula is shown in Formula 1, Formula 2 or Formula 3; in Formula 1, Formula 2 or Formula 3, Y is a trypsin cleavage site, Z is an active peptide, and n is a tandem repeat number; the n is ≥ 2; the amino acid sequence of the active peptide is shown in SEQ ID NO.1; (YZY)n Formula 1; GS-(YZY)n Formula 2; GS-(YZY)n-SG Formula 3. The present invention uses walnut-derived peptide EVSGPGYSPN as a template to design the recombinant tandem protein; the recombinant tandem protein can be used as a target protein and prepared by DNA recombination technology. Through the D-galactose-induced memory impairment model mouse water maze test, compared with the model group, the target quadrant residence time of the mice in the recombinant tandem protein treatment group increased from 21.22s to 31.23s, and the number of times passing the platform increased from 0.55 times to 1.20 times, which can prove that the recombinant tandem protein has the effect of improving the learning and memory ability of mice. BRIEF DESCRIPTION OF THE DRAWINGS

[0017] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative labor.

[0018] Figure 1 pGEX-6p1-(EY10) 18 / Rosetta (DE3) recombinant engineering bacteria induced expression results;

[0019] Figure 2 pET28a-(EY10) 18 / Rosetta (DE3) recombinant engineering bacteria induced expression results;

[0020] Figure 3 pET28a-GST-His-(EY10) 18 -GST-His / Rosetta (DE3) recombinant engineering bacteria induced expression results;

[0021] Figure 4 pET28a-(EY10) 12 / Rosetta (DE3) recombinant engineering bacteria induced expression results;

[0022] Figure 5 pET28a-(EY10) 18 / Results of induced expression of BL21(DE3) recombinant engineering bacteria at 37°C;

[0023] Figure 6 pET28a-(EY10) 18 / Results of Rosetta (DE3) recombinant engineering bacteria induced expression at 37°C;

[0024] Figure 7 pET28a-(EY10) 18 / Results of Rosetta (DE3) recombinant engineering bacteria induced expression at 28°C;

[0025] Figure 8 This is a diagram of the purification of the recombinant tandem protein precursor;

[0026] Figure 9 Dialysis and enzyme digestion purification diagram of recombinant tandem protein precursor;

[0027] Figure 10 Dialysis diagram of recombinant tandem proteins;

[0028] Figure 11 GS-(YZY) 18 The trajectory of the mouse in the Morris water maze navigation test with the recombinant tandem protein;

[0029] Figure 12 GS-(YZY) 18 The results of escape latency in Morris water maze navigation test of mice with recombinant tandem protein;

[0030] Figure 13 GS-(YZY) 18 The trajectory of mice in Morris water maze spatial exploration test with recombinant tandem protein;

[0031] Figure 14 GS-(YZY) 18 The time spent in the target quadrant in Morris water maze spatial exploration test of mice with recombinant tandem protein;

[0032] Figure 15 GS-(YZY) 18 Graph of the number of platform crossings in the Morris water maze spatial exploration test in mice with recombinant tandem proteins. DETAILED DESCRIPTION

[0033] The present invention provides a recombinant tandem protein for improving learning and memory ability, the general formula of which is shown in Formula 1, Formula 2 or Formula 3; in Formula 1, Formula 2 or Formula 3, Y is a trypsin cleavage site, Z is an active peptide, and n is a tandem repeat number; n≥2; the amino acid sequence of the active peptide is shown in SEQ ID NO.1; (YZY)n Formula 1; GS-(YZY)n Formula 2; GS-(YZY)n-SG Formula 3.

[0034] The present invention uses the derivative peptide EVSGPGYSPN (SEQID NO.1) of the walnut antioxidant active peptide EVSGPGLSPN (SEQ ID NO.5) as a template to design the recombinant tandem protein. The active peptide of the present invention is connected to trypsin cleavage sites at both ends, so that the recombinant tandem protein of the present invention can obtain the walnut derived peptide EVSGPGYSPN after trypsin digestion.

[0035] In the present invention, the molecular weight of the recombinant tandem protein is preferably 15 to 35 kDa.

[0036] In the present invention, n is preferably 18 or 12; when n is 18, the amino acid sequence of the recombinant tandem protein is as shown in SEQ ID NO.2 or SEQ ID NO.3, wherein the amino acid sequence shown in SEQ ID NO.2 is specifically:

[0037] GSKR EVSGPGYSPN KR EVSGPGYSPN KR EVSGPGYSPN KR EVSGPGYSPN KR EVSGPGYSPN KR EVSG PGYSPN KR EVSGPGYSPN KR EVSGPGYSPN KR EVSGPGYSPN KR EVSGPGYSPN KR EVSGPGYSPN KR EVSGPGYS PN KR EVSGPGYSPN KR EVSGPGYSPN KR EVSGPGYSPN KR EVSGPGYSPN KR EVSGPGYSPN KR EVSGPGYSPN KR, where the underlined amino acid sequence is the active peptide;

[0038] The amino acid sequence shown in SEQ ID NO.3 is specifically:

[0039] GSKR EVSGPGYSPN KR EVSGPGYSPN KR EVSGPGYSPN KR EVSGPGYSPN KR EVSGPGYSPN KR EVSGPGYSPN KR EVSGPGYSPN KR EVSGPGYSPN KR EVSGPGYSPN KR EVSGPGYSPN KR EVSGPGYSPN KR EVSGPGYS PN KR EVSGPGYSPN KR EVSGPGYSPN KR EVSGPGYSPN KR EVSGPGYSPN KR EVSGPGYSPN KR EVSGPGYSPN KRSG, in which the underlined amino acid sequence is the active peptide.

[0040] In the present invention, when n is 12, the amino acid sequence of the recombinant tandem protein is as shown in SEQ ID NO.4, specifically:

[0041] GSKR EVSGPGYSPN KR EVSGPGYSPN KR EVSGPGYSPN KR EVSGPGYSPN KR EVSGPGYSPN KR EVS GPGYSPN KR EVSGPGYSPN KR EVSGPGYSPN KR EVSGPGYSPN KR EVSGPGYSPN KR EVSGP GYSPN KR EVSGPGYSPN KR, where the underlined amino acid sequence is the active peptide.

[0042] The invention also provides a gene encoding the recombinant tandem protein.

[0043] In the present invention, when n is 18, the nucleotide sequence of the gene encoding the recombinant tandem protein is as shown in SEQ ID NO.6 or SEQ ID NO.7; the nucleotide sequence shown in SEQ ID NO.6 is specifically:

[0044] ggatccaaaagg gaagtatcagggcccggatatagtccgaac aagaga gaggttagcggtccgggcta tagtccgaac aaacgt gaagtttccggtccgggttattcgccgaac aagcgt gaagtgtccggtccgggctacagc ccgaat aagcgc gaggtttccggccctggttatagtccgaac aaacgt gaagtttctggtccgggttacagcccga at aaacgt gaagtttccggcccaggttatagcccaaat aaacgt gaggtgagcggtccgggctacagcccgaac aagcgc gaagtgagcggtccgggttacagcccgaac aaacgc gaggttagcggtccgggttatagcccgaac aagcgt gaagtttctggccctggttactccccgaac aaacgcgaggtatccggcccgggctattcgccgaac aagcgt gagg tgtctggcccaggttactctccgaac aaacgt gaagtcagcggtccgggttacagcccgaac aaacgt gaggtcag cggccctggctatagcccgaat aaacgt gaggtgtcaggcccgggttacagcccgaat aagcgc gaggtgagcgga ccgggctacagcccgaat aagcgc gaagtgtctggcccaggctactcgccgaac aagcgt; The nucleotide sequence shown in SEQ ID NO.7 is specifically:

[0045] ggatccaaaagg gaagtatcagggcccggatatagtccgaac aagaga gaggttagcggtccgggcta tagtccgaac aaacgt gaagtttccggtccgggttattcgccgaac aagcgt gaagtgtccggtccgggctacagc ccgaat aagcgc gaggtttccggccctggttatagtccgaac aaacgt gaagtttctggtccgggttacagcccga at aaacgt gaagtttccggcccaggttatagcccaaat aaacgt gaggtgagcggtccgggctacagcccgaac aagcgc gaagtgagcggtccgggttacagcccgaac aaacgc gaggttagcggtccgggttatagcccgaac aagcgt gaagtttctggccctggttactccccgaac aaacgc gaggtatccggcccgggctattcgccgaac aagcgt gagg tgtctggcccaggttactctccgaac aaacgt gaagtcagcggtccgggttacagcccgaac aaacgt gaggtcag cggccctggctatagcccgaat aaacgt gaggtgtcaggcccgggttacagcccgaat aagcgc gaggtgagcgga ccgggctacagcccgaat aagcgc gaagtgtctggcccaggctactcgccgaac aagcgtagcggc.

[0046] When n is 12, the nucleotide sequence of the gene encoding the recombinant tandem protein is as shown in SEQ ID NO.8, specifically:

[0047] ggatccaaaagg gaagtatcagggcccggatatagtccgaac aagaga gaggttagcggtccgggcta tagtccgaac aaacgt gaagtttccggtccgggttattcgccgaac aagcgt gaagtgtccggtccgggctacagc ccgaat aagcgc gaggtttccggccctggttatagtccgaac aaacgt gaagtttctggtccgggttacagcccga at aaacgt gaagtttccggcccaggttatagcccaaat aaacgt gaggtgagcggtccgggctacagcccgaac aagcgc gaagtgagcggtccgggttacagcccgaac aaacgc gaggttagcggtccgggttatagcccgaac aagcgtgaagtttctggccctggttactc cccgaac aaacgc gaggtatccggcccgggctattcgccgaac aagcgt.

[0048] In the present invention, the coding gene of the recombinant tandem protein is codon-optimized and suitable for expression in an Escherichia coli expression system.

[0049] In the specific implementation of the present invention, the coding gene of the recombinant tandem protein is synthesized by Nanjing GenScript Co., Ltd.

[0050] The present invention also provides a fusion protein, the general formula of which is shown in Formula 4, Formula 5 or Formula 6; in Formula 4, Formula 5 or Formula 6, each protein group is connected in series in sequence; in Formula 4 and Formula 5, L1 is a first protein purification tag, X is a TEV cleavage site, Y is a trypsin cleavage site, Z is an active peptide, and n is a number of tandem repeats; n≥2; in Formula 6, L2 is a second protein purification tag, X is a TEV cleavage site, Y is a trypsin cleavage site, Z is an active peptide, and n is a number of tandem repeats; n≥2; L1-X-(YZY)nX-L1 Formula 4; L1-X-(YZY)n Formula 5; L2-X-(YZY)n Formula 6.

[0051] In the present invention, the molecular weight of the fusion protein is preferably 10 to 100 kDa.

[0052] In the present invention, n is preferably 18 or 12.

[0053] In the present invention, L1 is preferably a GST tag and a His tag connected in series, that is, the general formula is: ABX-(YZY)nXAB or ABX-(YZY)n, wherein A is a GST tag and B is a His tag; L2 is preferably a His tag, that is, the general formula is: BX-(YZY)n, B is a His tag.

[0054] In the present invention, the protein groups in Formula 4, Formula 5 or Formula 6 are preferably connected by connecting polypeptides or connecting amino acids; A and B are preferably connected by TSGSS; B and X are preferably connected by SSGEF; X and (YZY)n are preferably connected by S; (YZY)n and X are preferably connected by S; X and A are preferably connected by SSG; and B and A are preferably connected by GSS.

[0055] In one embodiment of the present invention, the general formula of the fusion protein is ABX-(YZY)nXAB, and n is 18. The amino acid sequence of the fusion protein is shown in SEQ ID NO.9, specifically:

[0056] MSPILGYWKIKGLVQPTRLLLEYLEEKYEEHLYERDEGDKWRNKKFELGLEFPNLPYYIDGDVKLTQSMAIIRYIADKHNMLGGCPKERAEISMLEGAVLDIRYGVSRIAYSKDFETLKVDFLSKLPEMLKMFEDRLCHKTYLNGDHVTHPDFMLYDALDVVLYMDPMCLDAFPKLVCFKKRIEAIPQIDKYLKSSKYIAWPLQGWQATFGGGDHPPKTSGSSHHHHHHSSGEFENLYFQGSKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKRSGQFYLNESSGSPILGYWKIKGLVQPTRLLLEYLEEKYEEHLYERDEGDKWRNKKFELGLEFPNLPYYIDGDVKLTQSMAIIRYIADKHNMLGGCPKERAEISMLEGAVLDIRYGVSRIAYSKDFETLKVDFLSKLPEMLKMFEDRLCHKTYLNGDHVTHPDFMLYDALDVVLYMDPMCLDAFPKLVCFKKRIEAIPQIDKYLKSSKYIAWPLQGWQATFGGGDHPPKGSSHHHHHH。

[0057] In another embodiment of the present invention, the general formula of the fusion protein is B-X-(YZY)n and n is 18, and the amino acid sequence of the fusion protein is shown in SEQ ID NO.10, specifically:

[0058] HHHHHHSSGEFENLYFQGSKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREV SGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKR.

[0059] In another embodiment of the present invention, the general formula of the fusion protein is ABX-(YZY)n, where n is 18, and the amino acid sequence of the fusion protein is shown in SEQ ID NO.11, specifically:

[0060] MSPILGYWKIKGLVQPTRLLLEYLEEKYEEHLYERDEGDKWRNKKFELGLEFPNLPYYIDGDVKLTQSMAIIRYIADKHNMLGGCPKERAEISMLEGAVLDIRYGVSRIAYSKDFETLKVDFLSKLPEML KMFEDRLCHKTYLNGDHVTHPDFMLYDALDVVLYMDPMCLDAFPKLVCFKKRIEAIPQIDKYLKSSKYIAWPLQGWQATFGGGDHPPKTSGSSHHHHHHSSGEFENLYFQGSKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVS GPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKR.

[0061] In another embodiment of the present invention, the general formula of the fusion protein is ABX-(YZY)n, where n is 12, and the amino acid sequence of the fusion protein is shown in SEQ ID NO.12, specifically:

[0062] MSPILGYWKIKGLVQPTRLLLEYLEEKYEEHLYERDEGDKWRNKKFELGLEFPNLPYYIDGDVKLTQSMAIIRYIADKHNMLGGCPKERAEISMLEGAVLDIRYGVSRIAYSKDFETLKVDFLSKLPEMLKMFEDRLCHKTYLNGDHVTHPDFMLYDALDVVLYMDPMCLDAFPKLVCFKKRIEAIPQIDKYLK SSKYIAWPLQGWQATFGGGDHPPKTSGSSHHHHHHSSGEFENLYFQGSKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKREVSGPGYSPNKR.

[0063] The present invention also provides a gene encoding the fusion protein described in the above scheme.

[0064] In one embodiment of the present invention, the general formula of the fusion protein is ABX-(YZY)nXAB, and n is 18. The nucleotide sequence of the gene encoding the fusion protein is shown in SEQ ID NO.13, specifically:

[0065]

[0066] In another embodiment of the present invention, the general formula of the fusion protein is BX-(YZY)n, where n is 18, and the nucleotide sequence of the gene encoding the fusion protein is shown in SEQ ID NO.14, specifically:

[0067] catcatcatcatcatcacagcagcggcgaattcgaaaacctgtattttcagggatccaaaagggaagtatcagggcccggatatagtccgaacaaga.

[0068] In another embodiment of the present invention, the general formula of the fusion protein is ABX-(YZY)n, where n is 18, and the nucleotide sequence of the gene encoding the fusion protein is shown in SEQ ID NO.15, specifically:

[0069]

[0070] In another embodiment of the present invention, the general formula of the fusion protein is ABX-(YZY)n, where n is 12, and the nucleotide sequence of the gene encoding the fusion protein is shown in SEQ ID NO.16, specifically:

[0071]

[0072] In the present invention, the coding gene of the fusion protein is codon-optimized and is suitable for expression in an E. coli expression system.

[0073] In the specific implementation of the present invention, the gene encoding the fusion protein is synthesized by Nanjing GenScript Co., Ltd.

[0074] The present invention also provides a recombinant plasmid into which the coding gene of the fusion protein described in the above scheme is inserted.

[0075] In the present invention, when the general formula of the fusion protein is as shown in Formula 4 or Formula 5, the backbone plasmid of the recombinant plasmid is preferably pET28a; when the general formula of the fusion protein is as shown in Formula 6, the backbone plasmid of the recombinant plasmid is preferably pGEX-6p-1.

[0076] In the specific implementation of the present invention, the pET-28a and pGEX-6p-1 vectors were purchased from Miaoling Biotechnology Co., Ltd.

[0077] The present invention has no particular limitation on the method for constructing the recombinant plasmid, and conventional methods in the art may be used.

[0078] In one embodiment of the present invention, the recombinant plasmid is pGEX-6p1-(EY10) 18 The recombinant plasmid of this embodiment is adjusted on the basis of the general formula ABX-(YZY)nXAB. Since pGEX-6p1 itself carries a GST tag, the protein expression general formula is changed to BX-(YZY)n, wherein n=18. The nucleotide sequence of the coding gene constituting BX-(YZY)n is optimized according to the codon preference of Escherichia coli, and a BamHI nuclease cleavage site is inserted at its N-terminus, and a stop codon TGA and a BamHI nuclease cleavage site are added at the C-terminus. The nucleotide sequence is synthesized by Nanjing GenScript Co., Ltd. and integrated into the protein expression vector pGEX-6p1 to obtain the recombinant plasmid pGEX-6p1-(EY10) 18 .

[0079] In another embodiment of the present invention, the recombinant plasmid is pET28a-(EY10) 18The recombinant plasmid of this embodiment is adjusted on the basis of the general formula ABX-(YZY)nXAB. Since the tag is fused to the N-terminus of the tandem recombinant protein, the general formula of protein expression is changed to ABX-(YZY)n, wherein n=18. The nucleotide sequence of the coding gene constituting ABX-(YZY)n is optimized according to the codon preference of Escherichia coli, and an Nde I nuclease cleavage site is inserted at its N-terminus, a stop codon TGA, and a Hind III nuclease cleavage site are added to the C-terminus. The nucleotide sequence is synthesized by Nanjing GenScript Co., Ltd. and integrated into the protein expression vector pET28a to obtain the recombinant plasmid pET28a-(EY10) 18 .

[0080] In another embodiment of the present invention, the recombinant plasmid is pET28a-(EY10) 12 The recombinant plasmid of this embodiment is adjusted on the basis of the general formula ABX-(YZY)nXAB. Since the tag is fused to the N-terminus of the tandem recombinant protein, the general formula of protein expression is changed to ABX-(YZY)n, wherein n=12. The nucleotide sequence of the coding gene constituting ABX-(YZY)n is optimized according to the codon preference of Escherichia coli, and an Nde I nuclease cleavage site is inserted at its N-terminus, a stop codon TGA, and a Hind III nuclease cleavage site are added to the C-terminus. The nucleotide sequence is synthesized by Nanjing GenScript Co., Ltd. and integrated into the protein expression vector pET28a to obtain the recombinant plasmid pET28a-(EY10) 12 .

[0081] In another embodiment of the present invention, the recombinant plasmid is pET28a-GST-His-(EY10) 18 -GST-His; the tag was fused to the N-terminus and C-terminus of the tandem protein, and the general protein expression formula was ABX-(YZY)nXAB, wherein n=18. The nucleotide sequence of the coding gene constituting ABX-(YZY)nXAB was optimized according to the codon preference of Escherichia coli, and an Nde I nuclease cleavage site was inserted into the N-terminus, and a double stop codon TGA and a HindIII nuclease cleavage site were added to the C-terminus. The nucleotide sequence was synthesized by Nanjing GenScript Co., Ltd. and integrated into the protein expression vector pET28a to obtain the recombinant plasmid pET28a-GST-His-(EY10) 18 -GST-His.

[0082] The present invention also provides a recombinant bacterium comprising the recombinant plasmid described in the above scheme.

[0083] In the present invention, the original bacteria of the recombinant bacteria are preferably Escherichia coli, more preferably BL21 (DE3) or Rosetta (DE3), and most preferably Rosetta (DE3). In the specific implementation of the present invention, the BL21 (DE3) and Rosetta (DE3) are purchased from Weidi Biotechnology.

[0084] The present invention has no particular limitation on the method for constructing the recombinant bacteria, and conventional methods in the art may be used.

[0085] The present invention also provides the use of the recombinant tandem protein, the encoding gene of the recombinant tandem protein, the fusion protein, the encoding gene of the fusion protein, the recombinant plasmid or the recombinant bacteria described in the above scheme in the preparation of a product for improving learning and memory ability.

[0086] In the present invention, the improvement of learning and memory ability includes improving learning and memory ability after memory damage; the memory damage is preferably induced by D-galactose.

[0087] The present invention also provides a method for preparing the recombinant tandem protein described in the above scheme, comprising the following steps:

[0088] The recombinant bacteria described in the above scheme are mixed with an inducer, and induced culture is performed to obtain an induced expression product; the bacterial precipitate in the induced expression product is first purified to obtain a first purified product; the first purified product is enzymatically digested with TEV enzyme to obtain an enzymatic digestion product; the enzymatic digestion product is second purified to obtain a recombinant tandem protein.

[0089] The present invention first mixes the recombinant bacteria and the inducer described in the above scheme, performs induction culture, and obtains the induced expression product. In the present invention, the OD600 value of the recombinant bacteria is preferably 0.5-0.8; the inducer is preferably IPTG; the working concentration of the IPTG is preferably 0.5mM; the temperature of the induction culture is preferably 28°C or 37°C; the induction culture is preferably shaker culture; the speed of the shaker culture is preferably 200rpm; the time of the induction culture is preferably 9h. After the induction culture, the present invention preferably further includes centrifuging the obtained induced expression product and collecting the bacterial precipitate; the centrifugation condition is preferably 12000rpm centrifugation for 10min.

[0090] After obtaining the induced expression product, the present invention performs a first purification on the bacterial precipitate in the induced expression product to obtain a first purified product. In the present invention, the first purification is preferably performed using a gravity column containing 50 mL of Ni-NTA purification resin.

[0091] After obtaining the first purified product, the present invention uses TEV enzyme to digest the first purified product to obtain a digestion product.

[0092] After obtaining the enzyme cleavage product, the present invention performs a second purification on the enzyme cleavage product to obtain a recombinant tandem protein. In the present invention, the second purification is preferably performed using a gravity column containing 50 mL of Ni-NTA purification resin.

[0093] The preparation method of the present invention can use microbial fermentation of cheap substrates to mass-produce recombinant tandem proteins through fermentation engineering. The recombinant tandem proteins can be used as additives in foods, health products or medicines. It has strong potential for the development of functional foods that improve memory, and also has good application prospects for the development of memory-improving drugs and health products.

[0094] The present invention also provides a product for improving learning and memory ability, wherein the active ingredient includes the recombinant tandem protein described in the above scheme.

[0095] In the present invention, the product preferably includes food additives, food, health care products or medicines. In the present invention, the food preferably includes walnut peptide milk beverage, walnut peptide compound beverage or walnut peptide oral liquid. In the present invention, the health care products preferably include walnut peptide protein powder. In the present invention, the product for improving learning and memory ability preferably includes medicines for treating Alzheimer's disease (AD). In the present invention, the dosage form of the medicine preferably includes oral dosage form.

[0096] To further illustrate the present invention, the following detailed description of a recombinant tandem protein, fusion protein and its encoding gene and application for improving learning and memory ability provided by the present invention is provided in conjunction with the accompanying drawings and examples, but they should not be construed as limiting the scope of protection of the present invention.

[0097] Strains and plasmids: The expression strains BL21 (DE3) and Rosetta (DE3) were purchased from Weidi Biotechnology, and the pET-28a and pGEX-6p-1 vectors were purchased from Miaoling Biotechnology Co., Ltd.

[0098] Enzymes and reagents:

[0099] The enzymes used in molecular biology operations were purchased from Bio-Tech, and the corresponding operation steps were carried out in full accordance with the relevant product instructions.

[0100] The synthesis and sequencing of the genes encoding the recombinant tandem proteins and fusion proteins were completed by Nanjing GenScript Co., Ltd.

[0101] Other raw materials and auxiliary materials whose sources are not indicated are commercially available products.

[0102] Example 1: General formula of recombinant tandem protein

[0103] In order to increase the expression of walnut memory-improving peptide EVSGPGYSPN in Escherichia coli, a recombinant tandem protein of walnut memory-improving peptide EVSGPGYSPN was designed, and the general protein formula is: ABX-(YZY)nXAB. Among them: A is a GST tag, B is a His tag, X is a TEV cleavage site, Y is a trypsin cleavage site, Z is an active peptide, and n is the number of tandem repeats. Through codon optimization, an Escherichia coli expression system was constructed, and the recombinant tandem protein GS-(YZY)n was obtained by purification and separation-one-step enzyme cleavage method-purification and separation.

[0104] Example 2: pGEX-6p1-(EY10) 18 Recombinant plasmid construction

[0105] Adjustments were made based on the protein expression formula of Example 1. Since pGEX-6p1 itself carries a GST tag, the protein expression formula was changed to BX-(YZY)n, wherein n=18. The amino acid sequence of the protein is shown in SEQ ID NO.10. The nucleotide sequence (SEQ ID NO.14) of the coding gene constituting BX-(YZY)n was optimized according to the codon preference of Escherichia coli. At the same time, a BamHI nuclease cleavage site was inserted at its N-terminus, and a stop codon TGA and a BamHI nuclease cleavage site were added to the C-terminus. The nucleotide sequence was synthesized by Nanjing GenScript Co., Ltd. and integrated into the protein expression vector pGEX-6p1 to obtain the recombinant plasmid pGEX-6p1-(EY10). 18 , stored in glycerol strain Top10.

[0106] Example 3: pET28a-(EY10) 18 Recombinant plasmid construction

[0107] Adjustments were made based on the protein expression formula of Example 1. Since the tag was fused to the N-terminus of the tandem recombinant protein, the protein expression formula was changed to ABX-(YZY)n, wherein n=18. The amino acid sequence of the protein was shown in SEQ ID NO.11. The nucleotide sequence of the coding gene constituting ABX-(YZY)n (shown in SEQ ID NO.15) was optimized according to the codon preference of Escherichia coli. At the same time, an Nde I nuclease cleavage site was inserted at its N-terminus, a stop codon TGA, and a HindIII nuclease cleavage site were added to the C-terminus. The nucleotide sequence was synthesized by Nanjing GenScript Co., Ltd. and integrated into the protein expression vector pET28a to obtain the recombinant plasmid pET28a-(EY10). 18 , stored in glycerol strain Top10.

[0108] Example 4: pET28a-(EY10) 12Recombinant plasmid construction

[0109] Adjustments were made based on the protein expression formula of Example 1. Since the tag was fused to the N-terminus of the tandem recombinant protein, the protein expression formula was changed to ABX-(YZY)n, wherein n=12. The amino acid sequence of the protein was shown in SEQ ID NO.12. The nucleotide sequence of the coding gene constituting ABX-(YZY)n (shown in SEQ ID NO.16) was optimized according to the codon preference of Escherichia coli. At the same time, an Nde I nuclease cleavage site was inserted at its N-terminus, a stop codon TGA, and a HindIII nuclease cleavage site were added to the C-terminus. The nucleotide sequence was synthesized by Nanjing GenScript Co., Ltd. and integrated into the protein expression vector pET28a to obtain the recombinant plasmid pET28a-(EY10). 12 , stored in glycerol strain Top10.

[0110] Example 5: pET28a-GST-His-(EY10) 18 -GST-His recombinant plasmid construction

[0111] The recombinant tandem protein was fused with tags at the N-terminus and C-terminus, so the general formula of protein expression was the same as in Example 1, i.e., ABX-(YZY)nXAB, wherein n=18, and the amino acid sequence of the protein was shown in SEQ ID NO.9. The nucleotide sequence (SEQ ID NO.13) of the coding gene constituting ABX-(YZY)nXAB was optimized according to the codon preference of Escherichia coli, and an Nde I nuclease cleavage site was inserted at its N-terminus, and a double stop codon TGA and a HindIII nuclease cleavage site were added to the C-terminus. The nucleotide sequence was synthesized by Nanjing GenScript Co., Ltd. and integrated into the protein expression vector pET28a to obtain the recombinant plasmid pET28a-GST-His-(EY10) 18 -GST-His, stored in glycerol strain Top10.

[0112] Example 6: Construction of recombinant engineering bacteria of walnut-derived peptides that improve memory

[0113] The above recombinant plasmid pGEX-6p1-(EY10) 18 、pET28a-(EY10) 18 、pET28a-(EY10) 12 and pET28a-GST-His-(EY10) 18 -GST-His was transferred to Rosetta (DE3) and the above recombinant plasmid pGEX-6p1-(EY10) by heat shock method. 18 、pET28a-(EY10)18 、pET28a-(EY10) 12 and pET28a-GST-His-(EY10) 18 -GST-His was transferred into BL21(DE3) strain by heat shock method, and single clones were selected through resistance screening to construct multiple recombinant engineering bacteria. After sequencing, the sequence in the engineering bacteria was consistent with the design.

[0114] Example 7: Optimization of inducible expression conditions of recombinant tandem proteins

[0115] The exploration of induction time

[0116] 1. Small shaking bacteria

[0117] Prepare 15 ml of liquid LB containing the corresponding antibiotics in a 50 mL conical flask, inoculate a glycerol strain containing the target plasmid at a 1% inoculation rate, and shake the strain overnight at 37°C and 200 rpm for about 10 to 15 hours.

[0118] 2. Big shake inoculation

[0119] Inoculate the small shaken culture solution from the first step into 50 ml LB containing the corresponding antibiotics at a ratio of 1% to 2%. To increase dissolved oxygen, use a 250 ml conical flask, 37°C, 200 rpm and shake until the OD600 value reaches 0.5 to 0.8 (usually takes 2 to 4 hours).

[0120] 3. Blank control sampling (recorded as 0h)

[0121] Before adding the inducer IPTG, sample 1 ml of bacterial solution into a 1.5 ml centrifuge tube, centrifuge at 12000 rpm for 10 min, discard the supernatant, and store the precipitate at -20°C for later use.

[0122] 4. Add IPTG to the conical flask in step 3 to a final concentration of 0.5 mM and continue shaking at 37°C and 200 rpm.

[0123] 5. Sampling at different time points: The optimal shaking time is related to the expressed protein. Different proteins have different optimal shaking times. To find the optimal induction time, samples can be taken at different induction time points (sample at 1h, 2h, 3h, 5h, 7h, 9h, and 22h of induction, and the precipitate after centrifugation should be stored at -20℃).

[0124] After all samples are prepared, observe the expression of target protein in bacteria by SDS-PAGE. Figures 1 - 4 As shown, Figure 1 pGEX-6p1-(EY10) 18 / Rosetta (DE3) recombinant engineering bacteria induced expression results; Figure 2 pET28a-(EY10)18 / Rosetta (DE3) recombinant engineering bacteria induced expression results; Figure 3 pET28a-GST-His-(EY10) 18 -GST-His / Rosetta (DE3) recombinant engineering bacteria induced expression results; Figure 4 pET28a-(EY10) 12 / Results of induced expression of Rosetta (DE3) recombinant engineering bacteria.

[0125] Depend on Figures 1 - 4 It can be seen that pET28a-(EY10) 18 / Rosetta(DE3) recombinant engineering bacteria induced the highest protein production, followed by pET28a-(EY10) 12 / Rosetta(DE3) recombinant engineering bacteria, followed by pET28a-GST-His-(EY10) 18 -GST-His / Rosetta(DE3) recombinant engineering bacteria, the one with the lowest protein expression is pGEX-6p1-(EY10) 18 / Rosetta (DE3) recombinant engineering bacteria.

[0126] 6. Exploration of Induced Strains

[0127] pET28a-(EY10) 18 / Rosetta(DE3) and pET28a-(EY10) 18 / BL21(DE3) recombinant engineering bacteria were inoculated by small and large shaking until the OD600 value was 0.5-0.8 (usually 2-4 hours were required), IPTG was added to a final concentration of 0.5mM, and the shaking was continued at 37°C and 200rpm. After induction for 9 hours, samples were taken and centrifuged at 12000rpm for 10 minutes. The supernatant was discarded and the expression of the target protein in the bacteria was observed by SDS-PAGE. Figure 5 and Figure 6 shown.

[0128] Depend on Figure 5 and Figure 6 It can be seen that Rosetta (DE3) is more suitable for pET28a-(EY10) 18 Plasmids for inducible expression of recombinant tandem proteins.

[0129] 7. Exploration of induced temperature

[0130] pET28a-(EY10) 18 / Rosetta (DE3) recombinant engineering bacteria were inoculated by small and large shaking until the OD600 value was 0.5-0.8 (usually 2-4 hours were required), and IPTG was added to a final concentration of 0.5 mM after cooling on ice. The cells were placed in shaking incubators at 37°C and 28°C, respectively, and the shaking was continued at 200 rpm. After induction for 9 hours, samples were taken and centrifuged at 12000 rpm for 10 minutes. The supernatant was discarded and the expression of the target protein in the bacteria was observed by SDS-PAGE. Figure 6 and Figure 7 As shown. Figure 6 and Figure 7 It can be seen that 28℃ is more suitable for pET28a-(EY10) 18 / Rosetta(DE3) recombinant engineering bacteria induced expression of GS-(YZY) 18 Recombinant tandem protein (amino acid sequence is shown in SEQ ID NO.2).

[0131] Example 8: GS-(YZY) 18 Obtaining recombinant tandem protein precursor (fusion protein)

[0132] 1. pET28a-(EY10) 18 / Rosetta (DE3) recombinant engineering bacteria fermentation cells were resuspended in 400 mL PBS buffer according to 10 L of cells, homogenized five times under high pressure (pressure 600-700 Bar), centrifuged at 8000 rpm at 4°C for 30 min, and the supernatant was collected.

[0133] 2. Add 200 mL of supernatant to a gravity column containing 50 mL of Ni-NTA purification resin equilibrated with PBS buffer and incubate at 4°C for 60 min.

[0134] 3. Allow the mixed solution to flow out by gravity, and add 200 mL of PBS buffer containing 10 mM imidazole into the gravity column four times for washing.

[0135] 4. Add 400 mL of PBS buffer containing 20 mM imidazole to the gravity column for four times for secondary washing. Add 200 mL of PBS buffer containing 30 mM imidazole to the gravity column for four times for tertiary washing.

[0136] 5. Add 400 mL of PBS buffer containing 300 mM imidazole to the gravity column 4 times to elute the histidine-tagged protein on the column. Determine the protein concentration in the eluate by measuring the absorbance at 280 nm and set aside. Observe the purification status by SDS-PAGE. Figure 8 As shown. Figure 8 It can be seen that washing with PBS buffer containing 300 mM imidazole can obtain GS-(YZY) 18Recombinant tandem protein precursors.

[0137] Example 9: GS-(YZY) 18 Obtaining recombinant tandem proteins

[0138] 1. Put the above eluate into a dialysis bag (Jelup, 100Da) and dialyze with PBS dialysis solution, changing the solution every 2 hours until the conductivity of the external liquid is consistent with that of the PBS dialysis solution.

[0139] 2. Collect the dialyzed protein solution, add EDTA to a final concentration of 0.5 mM, add DTT to a final concentration of 1 mM, mix well, add TEV enzyme (add 1 U of enzyme to 1 mg of protein), and place at 30°C for enzymatic digestion overnight.

[0140] 3. Add the digested liquid to a gravity column containing 50 mL of Ni-NTA purification resin equilibrated with PBS buffer and incubate at 4°C for 60 min.

[0141] 4. Collect the flow-through liquid, which is the recombinant tandem protein.

[0142] 5. Rinse once more with 200 mL PBS buffer and collect the flow-through. Observe the dialysis, enzyme digestion and purification by SDS-PAGE. Figure 9 As shown. Fig. 9 It can be seen that the TEV enzyme can completely cleave the recombinant tandem protein precursor, and the flow-through washed with PBS buffer contains a single recombinant tandem protein.

[0143] 6. Place the above-mentioned flow-through into a dialysis bag for dialysis. Use RO water for dialysis. Change the solution every 2 hours until the conductivity of the external solution is consistent with that of RO water. Observe the dialysis status by SDS-PAGE. Fig.10 As shown. Fig.10 It can be seen that the state of the recombinant tandem protein remained well after dialysis.

[0144] 7. Put the liquid in the dialysis bag into a plastic reagent bottle and place it in a -80℃ refrigerator, then freeze-dry it for later use.

[0145] The yields of the recombinant tandem proteins are shown in Table 1.

[0146] Table 1 Yield of recombinant tandem proteins

[0147]

[0148] After plasmid selection, plasmid optimization, change of tandem number and optimization of induction temperature, pET28a-(EY10) was determined. 18 / Rosetta(DE3) had a maximum yield of 100 mg / L when induced at 28°C.

[0149] Example 10: pET28a-(EY10) 18 GS-(YZY) prepared by Rosetta(DE3) recombinant engineering bacteria 18 Recombinant tandem protein can improve learning and memory ability in D-galactose-induced memory impairment model mice

[0150] The mouse study was approved by the Experimental Animal Ethics Committee of Zhejiang A&F University (No. ZAFUAC202429) and followed the Guide for the Care and Use of Laboratory Animals issued by the European Commission. SPF-grade male C57BL / 6J mice (20–25 g, 5–6 weeks old) were purchased from Spectro (Suzhou) Biotechnology Co., Ltd. After the mice were acclimated for one week in the mouse room of the College of Animal Science and Technology of Zhejiang A&F University (temperature 20±2°C, relative humidity 55±5%, 12 / 12h light / dark cycle), they were subjected to simple tests, abnormal mice were eliminated, and the mice were randomly divided into 4 groups, 20 mice in each group (n=20), including a blank control group (Control), a model group (Model), a positive group (Positive) and a recombinant tandem protein group (Peptides); the blank control group: mice were gavaged with normal saline for 60 days, and normal saline was subcutaneously injected at the back of the neck for 60 days; the model group: mice were gavaged with normal saline for 60 days, and D-galactose (400 gm / kg) was subcutaneously injected at the back of the neck for 60 days; the positive group: mice were gavaged with piracetam solution (300 mg / kg) for 60 days, and D-galactose (400 gm / kg) was subcutaneously injected at the back of the neck for 60 days; the recombinant tandem protein group: mice were gavaged with GS-(YZY) 18 The recombinant tandem protein (60 mg / kg) was intragastrically administered to mice for 60 days, and D-galactose (400 gm / kg) was subcutaneously injected at the back of the neck for 60 days. After 60 days, the mice in each group were subjected to the following positioning navigation test and space exploration test.

[0151] 1. Positioning navigation test

[0152] Warm water at 20±2℃ was injected into a circular water maze pool with a diameter of 1200mm, and a platform (diameter 65mm) was placed in the northwest quadrant 1cm below the water surface. The experiment lasted for 6 days, with fixed time periods every day and one training session in each time period. At the beginning of training, the platform was placed in the northwest quadrant, and the mice were placed in the pool from the southeast quadrant facing the pool wall. The image acquisition system records the time it takes for the mice to find the platform (escape latency) and the swimming path. Morris water maze experimental method: After the mouse finds the platform or fails to find the platform within 120s, the experimenter guides it to the platform and lets it rest on the platform for 60s. The swimming path of the mouse from the entrance to the hidden platform is recorded by the computer acquisition system (see Fig.11 ) and escape latency (see Fig.12 ).

[0153] Compared with the blank group (Control), the model group (Model) mice had a long escape latency, indicating that the model group mice had memory impairment. Compared with the model group, the escape latency of the recombinant tandem protein (Peptides) was significantly shortened, and the escape latency of the recombinant tandem protein was similar to that of the positive group (Positive) and the blank group. The escape latency of the blank group, the positive group and the recombinant tandem protein also gradually shortened with the training time, while there was no significant change in the model group. This shows that the memory impairment of mice has been improved, so the recombinant tandem protein has the effect of improving the learning and memory ability of the D-galactose-induced memory impairment model mice.

[0154] 2. Space Exploration Experiment

[0155] On the 7th day, the original platform was removed and the mouse was placed into the pool from the southeast quadrant facing the pool wall. The image acquisition system recorded the swimming path of the mouse within 120 s (see Fig.13 ), target quadrant dwell time (see Fig.14 ) and the number of platform crossings (see Fig.15 ).

[0156] Compared with the blank group (Control), the target quadrant residence time and the number of crossing the original platform of the model group (Model) mice decreased, indicating that the model group mice had memory impairment. Compared with the model group, the target quadrant residence time of the recombinant tandem protein (Peptides) mice increased significantly from 21.22s to 31.23s, and the number of crossing the platform increased from 0.55 times to 1.20 times. This indicates that the recombinant tandem protein has the effect of improving the learning and memory ability of the D-galactose-induced memory impairment model mice.

[0157] Although the above embodiment describes the present invention in detail, it is only a part of the embodiments of the present invention, not all of the embodiments. People can also obtain other embodiments based on this embodiment without creativity, and these embodiments all fall within the protection scope of the present invention.

Claims

1. A recombinant tandem protein for improving learning and memory ability, characterized in that: The general formula is shown in Formula 1, Formula 2 or Formula 3; in Formula 1, Formula 2 or Formula 3, Y is a trypsin cleavage site, Z is an active peptide, and n is a tandem repeat number; n≥2; the amino acid sequence of the active peptide is shown in SEQ ID NO.1; (YZY)n Formula 1; GS-(YZY)n Formula 2; GS-(YZY)n-SG Formula 3.

2. The recombinant tandem protein according to claim 1, characterized in that The molecular weight of the recombinant tandem protein is 15 to 35 kDa; The n is 18 or 12; when n is 18, the amino acid sequence of the recombinant tandem protein is shown as SEQ ID NO.2 or SEQ ID NO.3; when n is 12, the amino acid sequence of the recombinant tandem protein is shown as SEQ ID NO.

4.

3. The gene encoding the recombinant tandem protein according to claim 1 or 2.

4. A fusion protein, characterized in that The general formula is shown in Formula 4, Formula 5 or Formula 6; in Formula 4, Formula 5 or Formula 6, each protein group is connected in series in sequence; in Formula 4 and Formula 5, L1 is the first protein purification tag, X is the TEV cleavage site, Y is the trypsin cleavage site, Z is the active peptide, and n is the number of tandem repeats; n≥2; in Formula 6, L2 is the second protein purification tag, X is the TEV cleavage site, Y is the trypsin cleavage site, Z is the active peptide, and n is the number of tandem repeats; n≥2; L1-X-(YZY)nX-L1 Formula 4; L1-X-(YZY)n Formula 5; L2-X-(YZY)n Formula 6; The L1 is preferably a GST tag and a His tag connected in series; and the L2 is preferably a His tag.

5. The gene encoding the fusion protein of claim 4.

6. A recombinant plasmid, characterized in that: A gene encoding the fusion protein according to claim 5 is inserted.

7. A recombinant bacterium, characterized in that: Comprising the recombinant plasmid according to claim 6.

8. Use of the recombinant tandem protein according to claim 1 or 2, the coding gene of the recombinant tandem protein according to claim 3, the fusion protein according to claim 4, the coding gene of the fusion protein according to claim 5, the recombinant plasmid according to claim 6 or the recombinant bacteria according to claim 7 in the preparation of a product for improving learning and memory abilities.

9. The method for preparing the recombinant tandem protein according to claim 1 or 2, characterized in that: The following steps are involved: The recombinant bacteria according to claim 7 and an inducer are mixed for induction culture to obtain an induced expression product; the bacterial precipitate in the induced expression product is subjected to a first purification to obtain a first purified product; the first purified product is digested with TEV enzyme to obtain a digestion product; the digestion product is subjected to a second purification to obtain a recombinant tandem protein.

10. A product for improving learning and memory ability, characterized in that: The active ingredient comprises the recombinant tandem protein according to claim 1 or 2 or the recombinant tandem protein prepared by the preparation method according to claim 9.

Citation Information

Cited By

  • Application of recombinant walnut derived peptide rWDP

    CN120392953A